Literature DB >> 23061775

Adverse drug reactions: when the risk becomes a reality for patients.

Anthony R Cox1, Tehreem F Butt.   

Abstract

Communications about the safety of medicines are complex and generally poorly performed. Discussions may not be initiated by healthcare professionals and the lack of a 'common language' to express risk can cause confusion. In the event of a serious adverse drug reaction, prior failures in communication can cause difficulties, and patients may fail to receive adequate information about the nature of their experience. How to communicate openly with patients in order to minimize distrust and maximize future benefits from medicines requires exploration.

Entities:  

Mesh:

Year:  2012        PMID: 23061775     DOI: 10.2165/11636140-000000000-00000

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  22 in total

1.  Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence.

Authors:  Charlotte Brown; Deena R Battista; Richard Bruehlman; Susan S Sereika; Michael E Thase; Jacqueline Dunbar-Jacob
Journal:  Med Care       Date:  2005-12       Impact factor: 2.983

2.  Internet accounts of serious adverse drug reactions: a study of experiences of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Tehreem F Butt; Anthony R Cox; Jan R Oyebode; Robin E Ferner
Journal:  Drug Saf       Date:  2012-12-01       Impact factor: 5.606

3.  What do doctors say when prescribing medications?: an examination of medical recommendations from a communication perspective.

Authors:  Bo Feng; Robert A Bell; Anthony F Jerant; Richard L Kravitz
Journal:  Health Commun       Date:  2011-04

4.  A patient's perspective: the impact of adverse drug reactions on patients and their views on reporting.

Authors:  S Lorimer; A Cox; N J Langford
Journal:  J Clin Pharm Ther       Date:  2011-05-18       Impact factor: 2.512

5.  Patients' reaction to the disclosure of rare dreaded adverse events.

Authors:  Liana Fraenkel; Ellen Peters
Journal:  Patient Educ Couns       Date:  2010-08-09

6.  Liability claims and costs before and after implementation of a medical error disclosure program.

Authors:  Allen Kachalia; Samuel R Kaufman; Richard Boothman; Susan Anderson; Kathleen Welch; Sanjay Saint; Mary A M Rogers
Journal:  Ann Intern Med       Date:  2010-08-17       Impact factor: 25.391

7.  Patient perspectives of patient-provider communication after adverse events.

Authors:  Christine W Duclos; Mary Eichler; Leslie Taylor; Javan Quintela; Deborah S Main; Wilson Pace; Elizabeth W Staton
Journal:  Int J Qual Health Care       Date:  2005-07-21       Impact factor: 2.038

8.  Which providers should communicate which critical information about a new medication? Patient, pharmacist, and physician perspectives.

Authors:  Derjung M Tarn; Debora A Paterniti; Bradley R Williams; Camille S Cipri; Neil S Wenger
Journal:  J Am Geriatr Soc       Date:  2009-01-17       Impact factor: 5.562

Review 9.  Patients' understanding of risk associated with medication use: impact of European Commission guidelines and other risk scales.

Authors:  Dianne C Berry; D K Raynor; Peter Knapp; Elisabetta Bersellini
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

10.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

View more
  5 in total

1.  Preaching to the converted - optimising adverse drug reaction reporting by dentists.

Authors:  M M Patel; D R Radford; D Brown
Journal:  Br Dent J       Date:  2014-07       Impact factor: 1.626

2.  The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.

Authors:  Priya Bahri; Alexander N Dodoo; Brian D Edwards; I Ralph Edwards; Irene Fermont; Ulrich Hagemann; Kenneth Hartigan-Go; Bruce Hugman; Peter G Mol
Journal:  Drug Saf       Date:  2015-07       Impact factor: 5.606

3.  Teratogenic risk perception and confidence in use of medicines in pairs of pregnant women and general practitioners based on patient information leaflets.

Authors:  Sofia Frost Widnes; Jan Schjøtt; Geir Egil Eide; Anne Gerd Granas
Journal:  Drug Saf       Date:  2013-06       Impact factor: 5.606

4.  Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association.

Authors:  Andreas Vilhelmsson; Tommy Svensson; Anna Meeuwisse; Anders Carlsten
Journal:  BMC Pharmacol Toxicol       Date:  2012-12-23       Impact factor: 2.483

5.  Focusing on risk communication about medicines: why now?

Authors:  Priya Bahri; Mira Harrison-Woolrych
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.